A Jurkat 76 based triple parameter reporter system to evaluate TCR functions and adoptive T cell strategies.
Ontology highlight
ABSTRACT: Adoptive T cell therapy using TCR transgenic autologous T cells has shown great potential for the treatment of tumor patients. Thorough characterization of genetically reprogrammed T cells is necessary to optimize treatment success. Here, we describe the generation of triple parameter reporter T cells based on the Jurkat 76 T cell line for the evaluation of TCR and chimeric antigen receptor functions as well as adoptive T cell strategies. This Jurkat subline is devoid of endogenous TCR alpha and TCR beta chains, thereby circumventing the problem of TCR miss-pairing and unexpected specificities. The resultant reporter cells allow simultaneous determination of the activity of the transcription factors NF-κB, NFAT and AP-1 that play key roles in T cell activation. Human TCRs directed against
SUBMITTER: Rosskopf S
PROVIDER: S-EPMC5915142 | biostudies-literature | 2018 Apr
REPOSITORIES: biostudies-literature
ACCESS DATA